ILMN
42
5
PFE
23
7
ES
34
3
GPC
40
3
BAC
53
3
CMG
72
5
AAP
24
6
WFC
79
4
HON
67
2
R
71
4
CL
58
2
CF
57
-2
MAS
58
2
ZION
65
2
AXP
71
2
TRIP
47
3
CMA
61
5
RSG
71
3
DNB
82
4
HST
49
-9
ILMN
42
5
PFE
23
7
ES
34
3
GPC
40
3
BAC
53
3
CMG
72
5
AAP
24
6
WFC
79
4
HON
67
2
R
71
4
CL
58
2
CF
57
-2
MAS
58
2
ZION
65
2
AXP
71
2
TRIP
47
3
CMA
61
5
RSG
71
3
DNB
82
4
HST
49
-9
Financhill
Back

Voyager Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
34

VYGR
Voyager Therapeutics

Last Price:
5.65
Seasonality Move:
0.53%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.69
Seasonality Move:
1.46%
Sell
34
Voyager Therapeutics (VYGR) is a Sell

Is Voyager Therapeutics a Buy, Sell or Hold?

  • The current Voyager Therapeutics [VYGR] share price is $5.66. The Score for VYGR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • VYGR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VYGR Stock Price Chart

What is Voyager Therapeutics's stock price today?

  • The Voyager Therapeutics share price today is $5.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VYGR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

VYGR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 38.71 Sell
Chaikin Money Flow: 208963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.84 - 7.18) Sell
Bollinger Bands (100): (5.98 - 8.06) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

VYGR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.71 Sell
20-day SMA: 6.45 Sell
50-day SMA: 6.5 Sell
200-day SMA: 7.76 Sell
8-day EMA: 5.76 Sell
20-day EMA: 6.21 Sell
50-day EMA: 6.55 Sell
200-day EMA: 7.38 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Voyager Therapeutics Earnings Growth & VYGR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.50 per share, and a decrease next year of $0.54 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Voyager Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):